Andrew Sinclair, Ph.D.
Board Member
Adicet Bio, Inc. (ACET)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Sinclair, Ph.D.
Andrew Sinclair, Ph.D. is recorded as Board Member at Adicet Bio, Inc. (ACET). Adicet Bio, Inc. reported in an 8-K filed June 7, 2024 that Andrew Sinclair, Ph.D. was appointed Class III Director, effective June 5, 2024.
“The stockholders of the Company elected Michael G. Kauffman, M.D., Ph.D. and Andrew Sinclair, Ph.D. as Class III directors of the Company, for a three-year term ending at the annual meeting of stockholders to be held in 2027 and until their successors have been duly elected and qualified or until their earlier resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-05–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Adicet Bio, Inc.
Other people whose current roles at this company are on record from its filings.
- Chen Schor CEO
- Nick Harvey CFO, Board Member
- Stewart Abbot COO
- Stewart Abbot, Ph.D. COO
- Don Healey CTO
- Don Healey, Ph.D. CTO
- Donald Healey CTO, Board Member
- Lloyd Klickstein CIO
- Blake Aftab Board Member
- Carl Gordon Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.